Haoxi Health Technology Limited HAO

2.90 (0.07) (2.36%) as of 25 Sep
Market cap
$1.8M
P/E
—
Insider Buys alert about insiders buying in the last 12 month
Jun '25 Jun '24 Jun '23 Dec '22 Jun '22 Dec '21 Jun '21
P/FCF ratio
0.00 0.00 0.00 — 0.00 0.00 0.00
P/Operating CF
0.00 0.00 0.00 — 0.00 0.00 0.00
P/B ratio
0.00 0.00 0.00 — 0.00 0.00 0.00
Price to Tangible BV
0.00 0.00 0.00 — 0.00 0.00 0.00
EV/Sales
0.00 0.00 0.00 — 0.00 0.00 0.00
EV/EBITDA
0.00 0.00 0.00 — 0.00 0.00 0.00
EV/Operating CF
1.11 2.77 0.00 — 0.00 0.00 0.00
EV/FCF
1.09 2.60 0.00 — 0.00 0.00 0.00
Quick Ratio
2.34 1.78 0.47 0.00 0.15 0.15 0.15
Current Ratio
5.05 3.98 1.43 0.00 0.22 0.22 0.22
Net Debt/EBITDA
4.12 (3.20) (0.37) (0.31) 0.54 (1.09) (1.09)
Debt/Assets
8.87% 7.32% 17.04% 3,235.06% 80.92% 0.00% 0.00%
Debt/Equity
0.11 0.10 0.49 0.00 (0.30) 0.00 0.00
Asset Turnover
1.77 4.86 12.63 0.00 29.75 29.75 0.00
Operating CF/Net income
(0.87) (0.58) (0.90) 0.00 (2.76) 0.00 0.00
Capex/Depreciation
(5.59) (5.23) (5.42) — (3.95) — —
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
27.06% 20.12% 1,924.21% 0.00% (16.29%) (15.90%) 0.00%
ROA
20.90% 12.94% 43.37% 352.21% 45.05% 45.05% 0.00%
ROIC
(11.71%) 18.66% 66.50% (202.75%) 0.00% 0.00% 0.00%
Return on Tangible Assets
24.49% 11.10% 78.12% 12,594.81% (15.74%) (15.74%) (15.74%)
Average Days of Receivables
5.12 1.71 0.10 0.00 0.09 0.09 0.09
Research and Development Expense of Revenue
0.24% 0.16% 0.21% — 0.63% 0.63% 0.63%
Selling, General and Administrative Expense of Revenue
8.68% 1.96% 2.86% 0.00% 1.72% 1.72% 1.72%
Intangible Assets out of Total Assets
0.08 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
0.18% 0.00% 0.00% — 0.00% 0.00% 0.00%
Graham Net Nets
0.00 0.00 0.00 — 0.00 0.00 0.00
Graham Number
0.00 0.00 0.00 — 0.00 0.00 0.00
Free Cash Flow Yield
0.00% 0.00% 0.00% — 0.00% 0.00% 0.00%
Revenue per Share
36,449.22 97,039.60 70,573.00 — 40,392.25 0.00 0.00
Operating CF per Share
(3,731.22) (1,495.20) (2,180.25) — (1,688.50) — —
Capex per Share
(2,311.11) (110.80) (113.75) — (21.75) — —
Free Cash Flow per Share
(6,042.33) (1,606.00) (2,294.00) — (1,710.25) — —
Cash per Share
9,576.11 13,311.40 3,008.00 — 733.75 0.00 0.00
Shareholders Equity per Share
19,307.11 22,544.00 3,916.25 — (3,664.25) 0.00 0.00
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 — —
Book value per Share
19,307.11 22,544.00 3,916.25 — (3,664.25) 0.00 0.00
Free Cash Flow
(5.44) (0.80) (0.92) — (0.68) — —
Working Capital
15.72 11.51 1.10 0.01 (1.56) (1.56) (1.56)
Capital Expenditures
(2.08) (0.06) (0.05) — (0.01) — —
Net Current Asset Value
15.39 11.15 0.78 (0.24) (1.56) (1.56) (1.56)
EV/EBIT
0.00 0.00 0.00 — 0.00 0.00 0.00
Capex to Sales
0.06 0.00 0.00 — 0.00 0.00 0.00
Net Profit Margin
11.82% 2.66% 3.44% 0.00% 1.51% 1.51% 1.51%
Other line items
Depreciation/Fixed assets
3.41 0.08 0.06 — 0.23 0.00 0.00
Cash ROIC
(12.42%) (4.59%) (28.78%) 0.00% 93.45% 0.80% 0.80%
Accounts Receivable Turnover
95.50 413.99 3,666.13 0.00 4,142.79 4,142.79 0.00
Accounts Payable Turnover
78.94 129.22 39.46 — 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 — 0.00 0.00 0.00
Average Days of Payables
1.76 5.21 0.76 — 29.93 0.00 0.00
Days of Inventory on Hand
0.00 0.00 0.00 — 0.00 0.00 0.00
Average Receivables
0.34 0.12 0.01 0.01 0.00 0.00 —
Average Payables
0.40 0.35 0.66 — — — —
Average Assets
18.55 9.99 2.24 0.28 0.54 0.54 —
Average Common Equity
14.32 6.42 0.05 — (1.50) (1.54) —

Fold the line items

Columns are period end dates